GW Pharmaceuticals Total Assets 2013-2019 | GWPH

GW Pharmaceuticals total assets from 2013 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • GW Pharmaceuticals total assets for the quarter ending March 31, 2019 were $0.750B, a 8.23% increase year-over-year.
  • GW Pharmaceuticals total assets for 2018 were $0.491B, a 10.75% increase from 2017.
  • GW Pharmaceuticals total assets for 2017 were $0.443B, a 31.39% decline from 2016.
  • GW Pharmaceuticals total assets for 2016 were $0.646B, a 45.36% increase from 2015.
GW Pharmaceuticals Annual Total Assets
(Millions of US $)
2018 $491
2017 $443
2016 $646
2015 $444
2014 $444
2014 $0
2013 $101
2012 $68
2012 $0
GW Pharmaceuticals Quarterly Total Assets
(Millions of US $)
Q1 2019 $750
Q4 2018 $756
Q2 2018 $579
Q1 2018 $629
Q4 2017 $693
Q2 2017 $474
Q1 2017 $501
Q4 2016 $549
Q2 2016 $346
Q1 2016 $378
Q4 2015 $418
Q3 2015 $444
Q2 2015 $469
Q1 2015 $276
Q4 2014 $300
Q3 2014 $314
Q2 2014 $335
Q1 2014 $203
Q4 2013 $101
Q3 2013 $95
Q2 2013 $96
Q1 2013 $68
Q4 2012 $68
Q3 2012 $68
Q2 2012 $0
Q1 2012 $59
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $5.007B $0.013B
GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.825B 29.16
Medtronic (MDT) Ireland $135.913B 19.41
Stryker (SYK) United States $78.520B 28.02
Boston Scientific (BSX) United States $59.297B 28.43
Baxter (BAX) United States $42.385B 26.71
EssilorLuxottica Societe Anonyme (ESLOY) France $29.267B 0.00
Coloplast (CLPBY) Denmark $25.937B 41.41
Zimmer Biomet Holdings (ZBH) United States $25.411B 16.33
Lonza Group Ag (LZAGY) Switzerland $25.385B 0.00
Terumo (TRUMY) Japan $21.889B 25.17
Smith & Nephew SNATS (SNN) United Kingdom $19.108B 0.00
ResMed (RMD) United States $17.890B 34.18
Canopy Growth (CGC) Canada $12.379B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.239B 48.98
Insulet (PODD) United States $7.299B 531.83
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Hill-Rom Holdings (HRC) United States $7.083B 21.47
Aurora Cannabis (ACB) Canada $7.048B 69.50
Perrigo (PRGO) Ireland $6.991B 11.82
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.299B 51.41
ICU Medical (ICUI) United States $5.103B 30.45
Neogen (NEOG) United States $3.388B 55.09
NuVasive (NUVA) United States $3.018B 24.64
Agios Pharmaceuticals (AGIO) United States $2.894B 0.00
Hutchison China MediTech (HCM) China $2.829B 0.00
National Vision Holdings (EYE) United States $2.507B 53.42
Quidel (QDEL) United States $2.307B 23.94
Aphria (APHA) $1.619B 0.00
Cardiovascular Systems (CSII) United States $1.549B 889.60
Phibro Animal Health (PAHC) United States $1.229B 18.42
AtriCure (ATRC) United States $1.216B 0.00
VAREX IMAGING (VREX) United States $1.171B 24.86
NanoString Technologies (NSTG) United States $1.107B 0.00
Lantheus Holdings (LNTH) United States $1.086B 28.83
PetIQ (PETQ) United States $1.002B 24.33
Quanterix (QTRX) United States $0.820B 0.00
Cerus (CERS) United States $0.773B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.761B 21.35
Omeros (OMER) United States $0.760B 0.00
MacroGenics (MGNX) United States $0.739B 0.00
TG Therapeutics (TGTX) United States $0.701B 0.00
LeMaitre Vascular (LMAT) United States $0.608B 29.43
Surmodics (SRDX) United States $0.538B 78.24
OraSure Technologies (OSUR) United States $0.525B 24.17
Meridian Bioscience (VIVO) United States $0.492B 15.03
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.465B 0.00
Vapotherm (VAPO) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.324B 22.45
BioLife Solutions (BLFS) United States $0.319B 99.82
Cytosorbents (CTSO) United States $0.246B 0.00
Zynex (ZYXI) United States $0.239B 24.60
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.186B 0.00
United Health Products (UEEC) United States $0.171B 0.00
Rockwell Medical (RMTI) United States $0.167B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.139B 7.32
Female Health (VERU) United States $0.138B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.97
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.079B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.056B 19.25
MRI INTERVENTNS (MRIC) United States $0.052B 0.00